|
contents | america | ||||
| ClinPhone Boosts Leading Market Position ClinPhone, the global leader in clinical technology solutions has appointed Michael Smyth as the V.P. of Product Management in its Trial Management Solutions Group. This group encompasses ClinPhone's CTMS, Site Manager and eLearning products. Michael will be based in the New Jersey office in the US where he will work closely with the development and sales teams to add functionality to the products, manage client relationships and understand market needs based on customer feedback, and increase the overall presence of ClinPhone's Trial Management Solutions within the global market. Michael joins ClinPhone with a wealth of experience in clinical and technology sales, having headed major sales operations in both Asia and Europe. Prior to working with ClinPhone, Michael held a number of senior positions at major organizations, including Business Development Director at Premier Research and most recently, Head of Global Strategic Accounts with VivoMetrics Inc. ClinPhone's robust Trial Management Solutions help customers work more efficiently, thereby saving valuable time while decreasing costs. ClinPhone CTMS, previously branded as TrialWorks, is a powerful, user-friendly application designed to collect and report on virtually every aspect of clinical study programs. ClinPhone Site Manager is a web-based clinical trial solution that enables Clinical Operations personnel to effectively manage all processes related to the selection and activation of clinical trial sites, as well as facilitate ongoing communication with active sites. ClinPhone eLearning is a web-based system used to train both investigative site personnel and internal users of our software products. ClinPhone works with many of the world's leading pharmaceutical and biotechnology companies to provide a wide range of eClinical Solutions. The company is the largest and most accomplished Clinical Technology Organization (CTO) in the industry, with experience in over 1, 950 trials. write your comments about the article :: © 2007 Exhibition News :: home page |